Leah Neufeld
Personalreferent bei IMMUNEERING CORPORATION
Vermögen: 14 341 $ am 30.04.2024
Profil
Leah R.
Neufeld is currently the Chief People Officer at Immuneering Corp.
Prior to her current position, she held various roles in human resources.
From 2009 to 2014, she was the Director of Human Resources at Daiichi Sankyo Pharma, Inc. Before that, from 2002 to 2009, she worked as a Manager of Human Resources at Johnson & Johnson.
From 2015 to 2019, she served as the Head of Human Resources at Intercept Pharmaceuticals, Inc. She then became the Vice President of People at Prevail Therapeutics, Inc. from 2019 to 2021.
In 2014, she was the Global Head of Human Resources at NPS Pharmaceuticals, Inc. Ms. Neufeld completed her undergraduate degree at American University and her graduate degree at The Johns Hopkins University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.03.2024 | 10 029 ( 0,03% ) | 14 341 $ | 30.04.2024 |
Aktive Positionen von Leah Neufeld
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNEERING CORPORATION | Personalreferent | 20.10.2022 |
Ehemalige bekannte Positionen von Leah Neufeld
| Unternehmen | Position | Ende |
|---|---|---|
| PREVAIL THERAPEUTICS INC. | Personalreferent | 01.01.2021 |
| INTERCEPT PHARMACEUTICALS, INC. | Personalreferent | 01.01.2019 |
| NPS PHARMACEUTICALS, INC. | Personalreferent | 01.01.2015 |
Daiichi Sankyo Pharma, Inc.
 Daiichi Sankyo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Daiichi Sankyo Co., Ltd., Daiichi Sankyo Pharma, Inc. is a company that manufactures and sells pharmaceutical products. The company is based in Parsippany, NJ. | Personalreferent | 01.01.2014 |
| JOHNSON & JOHNSON | Personalreferent | 01.01.2009 |
Ausbildung von Leah Neufeld
| American University | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IMMUNEERING CORPORATION | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Daiichi Sankyo Pharma, Inc.
Daiichi Sankyo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Daiichi Sankyo Co., Ltd., Daiichi Sankyo Pharma, Inc. is a company that manufactures and sells pharmaceutical products. The company is based in Parsippany, NJ. | Health Technology |
